Alerts will be sent to your verified email
Verify Email
NECLIFE
|
Nectar Lifesciences
|
Haleos Labs
|
Everest Organics
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
-0.71 % | 9.57 % | 12.73 % |
|
5yr Avg Net Profit Margin
|
-0.63 % | 4.57 % | 2.92 % |
|
Price to Book
|
0.33 | 1.77 | 5.38 |
|
P/E
|
0.0 | 20.08 | 60.59 |
|
5yr Avg Cash Conversion Cycle
|
81.28 Days | -0.85 Days | -87.83 Days |
|
5yr Average Interest Coverage Ratio
|
0.94 | 4.15 | 3.02 |
|
5yr Avg ROCE
|
7.51 % | 10.58 % | 19.01 % |
|
5yr Avg Operating Profit Margin
|
7.57 % | 10.06 % | 6.68 % |
|
5 yr average Debt to Equity
|
0.73 | 0.54 | 0.84 |
|
5yr CAGR Net Profit
|
-31.15 % | -2.24 % | -58.15 % |
|
5yr Average Return on Assets
|
-0.34 % | 4.11 % | 3.96 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
44.53 % | 71.41 % | 60.78 % |
|
Share Pledged by Promoters
|
99.6 % | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-11.27 % | 1.56 % | -13.37 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Nectar Lifesciences
|
Haleos Labs
|
Everest Organics
|
|---|